RecruitingNCT07727694

Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults

Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

1,600 participants

Start Date

Jul 1, 2026

Study Type

OBSERVATIONAL

Conditions

Pediatric Cancer

Summary

It involves collecting safety and efficacy data, under the actual conditions of use of off label and compassionate use medicines in children and adolescents approved in humans before 2007, using a validated tool (Ennov EDC) and relying on the network recognised pediatric hemato-oncology centers in Belgium and responsible for the organization of Pediatric National tumor boards which discuss each case of relapse in order to define the best therapeutic options.

Eligibility

Min Age: 0 YearsMax Age: 25 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying data collection for people with pediatric cancer. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 0 Years to 25 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERdata collection

In particular, the patient's demographic data, medical history, previous and concomitant treatments, data on the treatment of interest (legal framework, compassionate use/ off-label), dosage, start date, etc.), clinical data will be collected. biological (including molecular profiling of the tumor if available) and radiological follow-up, information on adverse effects.